Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team

Get up to date on how experts are integrating CDK4/6 inhibition into adjuvant treatment of early-stage breast cancer with a focused commentary, downloadable patient resource, slides, and an archived webcast from a live workshop.

Share

Program Content

Activities

CDK Inhibition in EBC
Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: January 23, 2024

Activities

CDK4.6i in EBC
Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 07, 2024

Expires: March 06, 2025

Activities

Adj CDK4/6i Toxicities
How I Manage Key Toxicities With Adjuvant CDK4/6 Inhibitors for Early Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2023

Activities

HR+/HER2- EBC Patient Resource
HR-Positive/HER2-Negative Early Breast Cancer Patient Resource: Questions for Your Care Team
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: January 18, 2024

Faculty

cover img faculity

Sarah Donahue, MPH, NP

Breast Medical Oncology Nurse Practitioner
Hellen Diller Comprehensive Cancer Center
University of California San Francisco
San Francisco, California

cover img faculity

Julia LaBarbera, MSN, RN, AGACNP-BC

  • Nurse Practitioner
    Division of Hematology/Oncology
    Department of Medicine
    University of California, Los Angeles
    Santa Monica, California

cover img faculity

Joyce O'Shaughnessy, MD

Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Chair, Breast Disease Committee
Sarah Cannon Research Institute
Texas Oncology
Dallas, Texas

cover img faculity

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with Breastcancer.org and Smart Patients Inc.

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation

Partners

Breastcancer.org

ProCE Banner

Smart Patients

ProCE Banner